Pfizer, BioNTech Plan to File on Friday to Use Vaccine in December
Representational: A heath worker draws the ‘Gam-COVID-Vac’, also known as ‘Sputnik V’, Covid-19 vaccine, from a vial during a post-registration phase trial in Moscow, Russia. (Photographer: Andrey Rudakov/Bloomberg)

Pfizer, BioNTech Plan to File on Friday to Use Vaccine in December

Bookmark

Pfizer Inc. and BioNTech SE said they plan to file on Friday for an emergency use authorization that could allow their Covid-19 vaccine to be used in the U.S. next month.

The U.S. drugmaker and its German partner said earlier this week that a final analysis of clinical trial data showed the shot was 95% effective at preventing the disease. The filing with the Food and Drug Administration could permit the vaccine to be administered to high-risk populations in the U.S. by the middle to the end of December, the companies said in a statement.

©2020 Bloomberg L.P.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.